Correlation Between Vercom SA and Genomtec

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vercom SA and Genomtec at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vercom SA and Genomtec into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vercom SA and Genomtec SA, you can compare the effects of market volatilities on Vercom SA and Genomtec and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vercom SA with a short position of Genomtec. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vercom SA and Genomtec.

Diversification Opportunities for Vercom SA and Genomtec

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Vercom and Genomtec is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Vercom SA and Genomtec SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genomtec SA and Vercom SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vercom SA are associated (or correlated) with Genomtec. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genomtec SA has no effect on the direction of Vercom SA i.e., Vercom SA and Genomtec go up and down completely randomly.

Pair Corralation between Vercom SA and Genomtec

Assuming the 90 days trading horizon Vercom SA is expected to generate 0.76 times more return on investment than Genomtec. However, Vercom SA is 1.31 times less risky than Genomtec. It trades about 0.06 of its potential returns per unit of risk. Genomtec SA is currently generating about -0.11 per unit of risk. If you would invest  11,250  in Vercom SA on April 23, 2025 and sell it today you would earn a total of  730.00  from holding Vercom SA or generate 6.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vercom SA  vs.  Genomtec SA

 Performance 
       Timeline  
Vercom SA 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vercom SA are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Vercom SA may actually be approaching a critical reversion point that can send shares even higher in August 2025.
Genomtec SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Genomtec SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in August 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Vercom SA and Genomtec Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vercom SA and Genomtec

The main advantage of trading using opposite Vercom SA and Genomtec positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vercom SA position performs unexpectedly, Genomtec can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genomtec will offset losses from the drop in Genomtec's long position.
The idea behind Vercom SA and Genomtec SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated